Research and Development Department (R&D)
Location and contract
This function can either be situated in Geneva, under Swiss employment contract and with a hybrid working requirement of 3 days per week on site at DNDI offices. Alternatively, the successful candidate could be located in Africa or in the EU, under a home-based working set up and with a local contract in the absence of a local DNDI office
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV), two successful mission-driven non-for-profit Product Development Partnership organizations (PDP), have joined forces to create an innovative, shared regulatory sciences platform. This unique collaboration leverages DNDi’s broad experience in developing and registering medicines for neglected diseases with MMV’s deep malaria-specific expertise to speed up the delivery of effective, affordable and lifesaving medicines for people who need them most. The shared regulatory science platform is led by DNDi’s Director of Regulatory Sciences, with MMV’s Chief Medical Officer/Director Clinical Development serving as the anchor point on MMV’s side.
We are now seeking a senior, visionary Regulatory Sciences Manager with global experience to further support the strategic regulatory leadership across both organizations’ R&D portfolios. Reporting to the Director of Regulatory Sciences at DNDi, this role will be deeply embedded across the joint DNDi–MMV regulatory sciences platform, alongside existing regulatory expertise in both organizations. In this role, the Regulatory Sciences Senior Manager will provide regulatory expertise and functional management across all stages of product development, from early development through registration, lifecycle management, and access, while serving as a shared resource to ensure efficient deployment of specialized regulatory capacity. The role manages interactions with regulatory authorities such as the European Medicines Agency, US Food and Drug Administration, Swissmedic, and Therapeutic Goods Administration of Australia, as well as WHO, national regulators in endemic countries and regional/continental authorities including the African Medicines Agency (AMA), to secure clear, predictable pathways to approval and access. The role also contributes to regulatory policy, capacity strengthening, and advocacy, ensuring that the priorities of patients in low and middle-income countries are fully represented in global regulatory approaches.
Why this role is unique:
What to expect in the recruitment process:
Shortlisted candidates can expect a structured recruitment process which includes three phases and is expected to span approximately 8 to 10 weeks from application to employment offer. The process typically includes:
Please note that the exact steps, sequencing and timelines may vary depending on the availability of candidates and stakeholders and may be adjusted as the process progresses.
We strongly encourage applications from candidates based outside the Geneva region, including candidates from disease-endemic countries, and welcome applications from people with disabilities. DNDi and MMV are committed to building diverse and inclusive teams and will make reasonable accommodations throughout the recruitment process where needed. For international hires relocating to Geneva, relocation support will be provided.
Important note for candidates
By applying to this position, you acknowledge that your application and personal data will be shared with both DNDi and MMV as part of the joint recruitment process. The employment contract will be issued by DNDi, while the role itself is embedded within, and will serve, the shared DNDi–MMV Regulatory Sciences Platform across both organizations’ programmatic portfolios.
DNDi is committed to building a diverse, equitable and truly inclusive organisation. Our success and global reach are dependent upon our ability to encourage diversity and draw on the skills, understanding and experience of all our people. We particularly welcome applications from those who are underrepresented in at DNDi and across the sector, especially women, and including, but not limited to, black and minority ethnic candidates, and those with other protected characteristic.